CompletedNot Applicable

Effects of Scalp Nerve Block With Ropivacaine on Postoperative Recovery Quality

China144 participantsStarted 2018-09-18

Plain-language summary

Patients undergoing elective meningeoma resection surgery will be randomly assigned to one of the following two groups. After anesthesia induction but before skull-pin insertion, one group will receive scalp nerve blocks with 0.5% ropivacaine, whereas the other group will receive scalp nerve blocks with 0.9% saline. The patients' postoperative recovery quality, which is evaluated by KPS score, peri-operative inflammatory responses, and post-operative pain degree will be evaluated and compared between the two groups.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. 18-75 years old;
✓. BMI 18-28 kg/m2;
✓. ASA Physical Status 1-2;
✓. Clinical diagnosis of primary Meningeoma and will have elective Meningeoma Resection Surgery;
✓. With an estimated surgery time of less than 4h;
✓. The incision will be conducted at the frontal, top or the temperal skull.

Exclusion criteria

✕. A history of previous brain surgery;
✕. Severe systemic disease (heart, lung, kidney, or immune system);
✕. Nerval or mental disorders;
✕. A history of addiction to opioids;
✕. Allergic to ropivacaine;
✕. Infection at block site or severe systemic infection;
✕. Refuse to attend the trial.

What they're measuring

KPS score

Timeframe: 7 days post-surgery

Trial details

NCT IDNCT03648034

SponsorRenJi Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-09-30

View on ClinicalTrials.gov More Meningioma trials